Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management
Extended half-life FIX (EHL-FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63-year-old patient with severe hemophilia B (sHB) treated with FIX-Fc fusion protein (rFIXFc) who underwent neurosurgery.
Anesthesia; Haemophilia B; Neurosurgery
Benitez Hidalgo O, Martinez Garcia MF, Bescos Cabestre A, Juarez Gimenez JC, Gironella Mesa M, Bosch Albareda F. Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management. Clin Case Reports. 2022 May;10(5):e05848.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/8056
The following license files are associated with this item: